Skip to main content

Table 5 Multivariable in-hospital risk factors associated with mortality and orotracheal intubation in the diabetes patients

From: Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies

Characteristic

In-hospital death risk factors OR (CI 95%)

In-hospital orotracheal intubation OR (CI 95%)

Covariables included in the logistic analysis

Age

Cardiopathy

CDK

1.072 (1.003–1.15)

7.11 (0.16–3.98)

NS

1.034 (1.001–1.068)

NS

4.95–1.11–22.02)

Age and gender and all comorbidities

Vasoactive drug

CLHO/HCQ

11.73 (3.07–44.87)

3.99 (1.05–15.21)

227.03 (43.19–1193-43)

31.10 (6.43–150-38)

CLHO/HCQ. In-hospital metformin therapy; Pre-hospital metformin therapy; In-hospital insulin therapy; Dexamethasone/prednisolone

NEWS

In-hospital metformin therapy

1.71 (1.18–2.49)

0.034 (0.002–0.58)

NS

NS

Orotracheal intubation; prona; prisma; vasoactive drug, CLHO/HCQ. NEWS, In-hospital metformin therapy; Pre-hospital metformin therapy; In-hospital insulin therapy; Dexamethasone/prednisolone

  1. Neoplasia/immune, Neoplasia/immunosuppression; NEWS, National Early Warning Score; Prisma, prisma hemodialysis machine; Prona, prone position; CLHO/HCQ, Chloroquine/hydroxychloroquine, NS, not significant